导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -9.89% | 3739/4773 |
| 近一周 | -2.24% | 1570/5462 |
| 近一月 | -1.37% | 929/5421 |
| 近一季 | -4.55% | 1659/5209 |
| 近半年 | -7.90% | 3285/4920 |
| 近一年 | -6.92% | 3201/4366 |
| 近两年 | 33.87% | 2131/2954 |
| 近三年 | 27.13% | 1177/2253 |
| 成立以来 | 52.29% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-8.77% 4319/4961 |
2.22% 2970/5312 |
- - |
- - |
| 2025 | 16.77% 2415/4813 |
5.36% 789/3635 |
-5.04% 3529/4076 |
15.62% 2790/4524 |
0.95% 1644/4813 |
| 2024 | 25.62% 254/3463 |
6.68% 278/2808 |
-0.83% 851/3014 |
17.50% 1176/3129 |
1.05% 1127/3463 |
| 2023 | 5.57% 184/2656 |
10.35% 371/2280 |
5.41% 67/2385 |
-4.71% 1207/2515 |
-4.75% 1157/2655 |
| 2022 | -21.00% 1006/2207 |
-21.99% 1679/1919 |
16.60% 148/2016 |
-11.67% 555/2113 |
-1.68% 1727/2208 |
| 2021 | -8.48% 1051/1822 |
-0.60% 377/1255 |
3.05% 982/1330 |
-16.69% 1401/1466 |
7.26% 187/1822 |
| 2020 | - - |
- - |
18.18% 350/1067 |
14.15% 297/1164 |
16.57% 159/1184 |
| 2019 | - - |
- - |
- - |
- - |
- - |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 万家中证港股通创新药ETF | 1.5896 | 28.31% |
| 景顺长城中证港股通创新药ETF | 1.6507 | 28.23% |
| 港股医疗 | 0.9366 | 28.18% |
| 港股医疗ETF | 1.4282 | 28.15% |
| 港股通医疗ETF工银 | 0.9464 | 28.06% |
| 港股通医疗ETF华宝 | 0.9577 | 27.97% |
| 天弘恒生沪深港创新药精选50ETF发起联接C | 1.2844 | 27.92% |
| 天弘恒生沪深港创新药精选50ETF | 0.8437 | 27.35% |
| 万家中证港股通创新药ETF发起式联接A | 1.3863 | 27.32% |
| 万家中证港股通创新药ETF发起式联接C | 1.3856 | 27.27% |
| 国泰中证全指家电ETF VS. 长安沪深300非周期A(740101) |